Subcutaneous #infliximab maintenance demonstrated consistent clinical and endoscopic efficacy across #CrohnsDisease locations.
Read more insights on #LIBERTYCD trial from Dr Colombel, of Icahn School of Medicine. #GISky #IBDSky
www.docwirenews.com/post/subcuta...
Read more insights on #LIBERTYCD trial from Dr Colombel, of Icahn School of Medicine. #GISky #IBDSky
www.docwirenews.com/post/subcuta...
Subcutaneous Infliximab for CD by Location | Docwire News
Subcutaneous infliximab in maintenance showed consistent clinical, endoscopic efficacy across Crohn’s disease locations, including the terminal ileum.
www.docwirenews.com
April 23, 2026 at 9:41 PM
Subcutaneous #infliximab maintenance demonstrated consistent clinical and endoscopic efficacy across #CrohnsDisease locations.
Read more insights on #LIBERTYCD trial from Dr Colombel, of Icahn School of Medicine. #GISky #IBDSky
www.docwirenews.com/post/subcuta...
Read more insights on #LIBERTYCD trial from Dr Colombel, of Icahn School of Medicine. #GISky #IBDSky
www.docwirenews.com/post/subcuta...